Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia Post author: Post published:June 1, 2026 Post category: Continue ReadingAutologous Muscle Derived Cells for Treatment of Tongue Dysphagia
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant Post author: Post published:June 1, 2026 Post category: Continue ReadingGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia Post author: Post published:April 20, 2026 Post category: Continue ReadingA Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies Post author: Post published:April 20, 2026 Post category: Continue ReadingCD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
Stem Cell Gene Therapy for Sickle Cell Disease Post author: Post published:April 20, 2026 Post category: Continue ReadingStem Cell Gene Therapy for Sickle Cell Disease
Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease Post author: Post published:April 20, 2026 Post category: Continue ReadingStudy of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE) Post author: Post published:April 20, 2026 Post category: Continue ReadingA Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma Post author: Post published:April 20, 2026 Post category: Continue ReadingBrain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency Post author: Post published:April 20, 2026 Post category: Continue ReadingClinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency
Stem Cell Therapy for Limbal Stem Cell Deficiency Post author: Post published:April 20, 2026 Post category: Continue ReadingStem Cell Therapy for Limbal Stem Cell Deficiency